Fu, Dun Jack http://orcid.org/0000-0003-2852-6912
Hanumunthadu, Daren
Keenan, Tiarnan D. L. http://orcid.org/0000-0002-2253-1772
Wagner, Siegfried
Balsakas, Konstantinos
Keane, Pearse A. http://orcid.org/0000-0002-9239-745X
Patel, Praveen J. http://orcid.org/0000-0001-8682-4067
Article History
Received: 5 December 2021
Revised: 9 June 2022
Accepted: 16 August 2022
First Online: 9 September 2022
Competing interests
: Dr. Patel, Dr. Keane, and Dr. Balaskas have received a proportion of their funding from the Department of Health’s NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology. Dr. Keane has acted as a consultant for DeepMind, Roche, Novartis, and Apellis and is an equity owner in Big Picture Medical. He has received speaker fees from Heidelberg Engineering, Topcon, Allergan, and Bayer. Dr. Keane is supported by a Moorfields Eye Charity Career Development Award (R190028A) and a UK Research & Innovation Future Leaders Fellowship (MR/T019050/1). Dr. Balakas has received speaker fees from Novartis, Bayer, Alimera, Allergan, and Heidelberg, consulting fees from Novartis and Roche, and research support from Apellis, Roche, Novartis, and Bayer. Dr. Patel has received speaker fees from Novartis, Bayer, Topcon, and Heidelberg, consulting fees from Novartis, Bayer, Oxford Bioelectronics, and Roche, and research support from Bayer. Dr. Fu has acted as consultant for Abbvie, Allergan, DeepMind.